ARTICLE | Clinical News
CancerTYPE ID test regulatory update
August 1, 2011 7:00 AM UTC
bioMerieux's bioTheranostics Inc. subsidiary said that an administrator for Medicare Part B issued a positive coverage determination to allow reimbursement for its CancerTYPE ID test to aid in the det...